Retractable Technologies

Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. It offers injection devices, blood collection devices, and infusion devices. The company was founded by Thomas J. Shaw on May 9, 1994 and is headquartered in Little Elm, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Atai Life Sciences BV

Standard BioTools Inc

Limelight Networks

Penny stocks to buy according to these insiders. The post Penny Stocks To Buy Now?

Penny Stocks To Buy Now? Insiders Threw Big Money At These 4 Stocks

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that, effective April 14, 2022, it has terminated its Rule 10b5-1/10b-18 Repurchase Plan dated June 4, 2021. Since June 2021, Retractable has purchased a total of 1,087,145 shares for approximately $8.1 million under the Plan. The Board of Directors determined to cancel the plan because the stock price appears not to be correlated with the economic performance of the corporation at this time. This de

Retractable Technologies, Inc. Announces Termination of Buyback Plan

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2021. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed on March 31, 2022 with the U.S. Securities and Exchange Commission. OPERATIONS Our revenues for 2021 materially increased over prior years in large part due to demand for vaccines during the COVID-19 pandem

Retractable Technologies, Inc. Reports Results for 2021

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $44.1 million for the first nine months of 2021, compared to an operating income for the same period last year of $11.8 million, and that income applicable to common shareholders was $35.0 million for the first nine months of 2021 compared to $14.7 million in the prior year. Net sales were $36.4 million for the three months ended September 30, 2021 and $128.9 million for

Retractable Technologies, Inc. Reports $44.1 Million in Operating Income for the First Nine Months Of 2021

Associated Capital Group

Cass Information Systems

Diamond Hill Investment Group

IES Holdings

Miller Industries

Marine Products

Preformed Line Products

Seneca Foods

Tiptree

Universal Health Realty Income Trust

The market is peppered with undiscovered gems boasting stable fundamentals and cheap valuations. Here are 12 of the best stocks flying under the radar.

12 of the Best Stocks You Haven't Heard Of

AbbVie

Biogen

Intuitive Surgical

There's a reason why there are so few of them in his portfolio.

Here's What Warren Buffett Looks For With Healthcare Stocks

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B Convertible Preferred Stock in the amount of $39,050. The dividend amount is $0.25 per share. Dividends have accrued at 10% per annum and cover amounts in arrears from July 1, 2021 through date of conversion or September 30, 2021 whichever is applicable. The dividends will be paid on October 22, 2021 to sha

Retractable Technologies, Inc. Declares Dividends to Series II Class B Convertible Preferred Stock Shareholders

Retractable Technologies is a name that continues to fly under the radar of analysts and investors alike. The company's segment revenue and FCFF conversion have exhibited stellar growth in the last 2-4 year period, with 94% FCFF conversion from the top in Q2.

Retractable Technologies: Unfairly Punished, ~27% Upside Potential Under-Reflected

DENTSPLY SIRONA

Their products are never going out of style, and their valuations are attractive.

2 Evergreen Value Stocks You Could Buy and Hold Forever

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $36.1 million for the first six months of 2021, compared to an operating income for the same period last year of $1.4 million, and that income applicable to common shareholders was $28.5 million for the first six months of 2021 compared to $3.7 million in the prior year. Net sales were $42.5 million for the three months ended June 30, 2021 and $92.6 million for the six m

Retractable Technologies, Inc. Reports $36.1 Million in Operating Income for the First Six Months Of 2021

Align Technology

STAAR Surgical

Their business models are timeless, and their revenue is rising.

3 Value Stocks That Won't Stop Growing

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has approved the adoption of a repurchase plan (the “Plan”) for up to $10 million of its Common Stock. Under the Plan, open market purchases of Retractable's Common Stock may commence June 18, 2021 and may continue until June 18, 2022 at the latest. The Plan is structured to comply with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934. The Plan wil

Retractable Technologies, Inc. Announces Buyback Plan and Payment of All Dividends

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that it has entered into an amendment to delivery order 75A50120F33003 from the Department of Health and Human Services which was awarded May 1, 2020. The amendment changes the period of performance end date from May 2021 to March 2022 and reallocates the products ordered to increase shipments of 1mL low dead-space safety syringes. The previously disclosed total contract price and freight cos

Retractable Technologies, Inc. Amends HHS Delivery Order

The stock price of Retractable Technologies, Inc. (NYSEAMERICAN: RVP) increased by over 10%. This is why it happened.

RVP Stock Price: Over 10% Increase Explanation

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that, in accordance with the 30 day notice requirement, it received a preliminary notice from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (“HHS/ASPR”) expressing its intent to exercise all seven one-month option periods under 75A50121P00021 contract between HHS/ASPR and Retractable. Such option exercises would extend the co

Retractable Technologies, Inc. Receives Notice of Intent to Extend Government Contract

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies Inc. (NYSE American: RVP) announced today that it has entered into an amendment to the Technology Investment Agreement (originally awarded on July 1, 2020) with the U.S. government providing $27,365,232 in additional funding. The amendment calls for an increase in existing domestic manufacturing capabilities by a minimum of 50 percent in order to meet ongoing and future U.S. COVID-19 medical countermeasures demands. In order to satisf

Retractable Technologies, Inc. to Receive Additional Funding From U.S. Government Under Technology Investment Agreement

GameStop

Virgin Galactic

It's time to reacquaint your trading account with a better investment today in three of the market's most-shorted stocks. The post 3 Most-Shorted Stocks Ready to Buy Today appeared first on InvestorPlace.

3 Most-Shorted Stocks Ready to Buy Today

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $23.4 million in the first quarter of 2021, compared to operating income for the same period last year of $481 thousand. In comparison, the annual operating income for the prior two years was $24.1 million in 2020 and $3.0 million in 2019. During the first quarter of 2021, sales to the U.S. government were $37.8 million, representing 75.5% of the $50.1 million in first q

Retractable Technologies, Inc. Reports $23.4 Million in Operating Income for First Quarter Of 2021

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2020. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed on March 31, 2021 with the U.S. Securities and Exchange Commission. OPERATIONS As our syringes are used for vaccinations, our revenues for 2020 materially increased over prior years due to demand during the

Retractable Technologies, Inc. Reports Results For 2020

Digital Turbine

Community Health Systems

Inari Medical

Novavax

Bancorp

Veritone

VirnetX

XBiotech

These are the small-cap stocks with the best value, fastest growth, and most momentum for March 2021.

Top Small-Cap Stocks for March 2021

Retractable Technologies Inc. said in a securities filing on Feb. 16 that it was awarded a $54.2 million contract from the federal government. to supply low dead space safety syringes.

Retractable Technologies gets $54 million to supply syringes to the U.S. for COVID-19 vaccination

Retractable Technologies saw its IBD SmartSelect Composite Rating jump to 96 Thursday, up from 94 the day before. The post Retractable Technologies Receives IBD Stock Rating Upgrade appeared first on Investor's Business Daily.

Retractable Technologies Receives IBD Stock Rating Upgrade

Investing in the recovery from the pandemic could pay off big.

These 3 Healthcare Stocks Are the Best Bets for 2021

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $10,041 and $39,050, respectively. Over the entire accrual period, the dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and

Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders

AdaptHealth Corp

iRhythm Technologies

Sanara MedTech Inc.

Zai Lab Ltd.

These companies made millions by developing equipment for life-saving care, and enriched shareholders too.

These Were the 5 Best Medical Device Stocks of 2020

News for Retractable Technologies Stock (RVP)